The Indonesia Biopharmaceutical Summit 2025 brings together global leaders from academia, industry, regulatory agencies, and healthcare institutions to discuss the future of biologics — including monoclonal antibodies, gene therapies, and other advanced biological medicines that are transforming modern healthcare.

As biologics continue to redefine treatment for complex diseases such as cancer and autoimmune disorders, ensuring their accessibility and affordability remains a global challenge. This summit aims to bridge the gap between scientific innovation and patient access through collaborative dialogue, science-based regulation, and sustainable policy frameworks.

By fostering interdisciplinary collaboration and promoting regulatory agility, the summit seeks to accelerate the development and delivery of biologic therapies — ensuring that breakthroughs in science translate into meaningful health improvements for people everywhere.